Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes
[12] Metformin: Anchor in the GLP-1 RA Care Continuum Journey The mechanistic, real-world, clinical trials and pharmacovigilance evidence landscape suggests metformin as the potential anchor pharmacological agent across the entire GLP-1 RA care continuum, during therapy and beyond.Table 1 summarises the key potential outcome benefits at each phase
[DOI] [PMC free article] [PubMed] [Google Scholar] 47.Gurnari C, Pagliuca S, Prata PH, Galimard JE, Catto LFB, Larcher L, Sebert M, Allain V, Patel BJ, Durmaz A, et al
Many patients find that dose increases should be delayed by one week if nausea persists, allowing a smoother transition and more predictable weight-loss outcomes
If you have pain, instead of NSAIDs, use Tylenol
Your primary goal is to protect the medication from extreme temperatures and physical damage